Aplastic anemia is a relatively rare but potentially fatal disorder, with a reported higher incidence in developing countries in comparison to the West. There are significant variations in epidemiological as well as etiological factors of bone marrow failure syndromes in the developing countries in comparison to the developed world. Furthermore, the management of bone marrow failure syndromes in resource constraint settings has significant challenges including delayed diagnosis and referral, limited accessibility to healthcare facilities, treatment modalities as well as limitations related to patients who require allogeneic stem cell transplantation. Here we will provide a review of the available evidence related to specific issues of aplas...
Bone marrow (BM) is the preferred graft source for hematopoietic stem cell transplantation (HSCT) in...
Aplastic anemia is a rare disorder characterized by pancy-topenia and hypoplastic bone marrow.1 Enti...
The diagnosis of aplastic anemia in children requires exclusion of a variety of inherited or acquire...
The bone marrow failure states, aplastic anemia and myelodysplastic syndrome, are characterized by r...
Acquired aplastic anemia (AA) is a rare heterogeneous disease characterized by pancytopenia and hypo...
Acquired aplastic anaemia is a rare, serious, immunologically mediated bone marrow failure syndrome,...
Severe aplastic anemia (SAA) is a serious bone marrow disease that needs a comprehensive and service...
This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and ther...
In recent years, it has become increasingly apparent that bone marrow (BM) failures and myeloid mali...
In recent years, it has become increasingly apparent that bone marrow (BM) failures and myeloid mali...
In recent years, it has become increasingly apparent that bone marrow (BM) failures and myeloid mali...
In recent years, it has become increasingly apparent that bone marrow (BM) failures and myeloid mali...
Although recent advances in therapy offer the promise for improving survival in patients with severe...
Acquired severe aplastic anemia (SAA) is a rare hematologic disease associated with significant morb...
Bone marrow (BM) is the preferred graft source for hematopoietic stem cell transplantation (HSCT) in...
Bone marrow (BM) is the preferred graft source for hematopoietic stem cell transplantation (HSCT) in...
Aplastic anemia is a rare disorder characterized by pancy-topenia and hypoplastic bone marrow.1 Enti...
The diagnosis of aplastic anemia in children requires exclusion of a variety of inherited or acquire...
The bone marrow failure states, aplastic anemia and myelodysplastic syndrome, are characterized by r...
Acquired aplastic anemia (AA) is a rare heterogeneous disease characterized by pancytopenia and hypo...
Acquired aplastic anaemia is a rare, serious, immunologically mediated bone marrow failure syndrome,...
Severe aplastic anemia (SAA) is a serious bone marrow disease that needs a comprehensive and service...
This issue of eMedRef provides information to clinicians on the pathophysiology, diagnosis, and ther...
In recent years, it has become increasingly apparent that bone marrow (BM) failures and myeloid mali...
In recent years, it has become increasingly apparent that bone marrow (BM) failures and myeloid mali...
In recent years, it has become increasingly apparent that bone marrow (BM) failures and myeloid mali...
In recent years, it has become increasingly apparent that bone marrow (BM) failures and myeloid mali...
Although recent advances in therapy offer the promise for improving survival in patients with severe...
Acquired severe aplastic anemia (SAA) is a rare hematologic disease associated with significant morb...
Bone marrow (BM) is the preferred graft source for hematopoietic stem cell transplantation (HSCT) in...
Bone marrow (BM) is the preferred graft source for hematopoietic stem cell transplantation (HSCT) in...
Aplastic anemia is a rare disorder characterized by pancy-topenia and hypoplastic bone marrow.1 Enti...
The diagnosis of aplastic anemia in children requires exclusion of a variety of inherited or acquire...